Dermapharm Holding SE (ETR:DMP)
Germany · Delayed Price · Currency is EUR 40.30
+0.25 (0.62%)
Aug 19, 2026, 5:35 PM CET
Dermapharm Holding SE Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Dermapharm Holding SE stock has a consensus rating of "Buy" and an average price target of €50.38. The average 1-year stock price forecast is 25.01% higher than the current stock price, while the lowest is €44.00 (+9.18%) and the highest is €60.00 (+48.88%).
Price Target: €50.38 (+25.01%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Dermapharm Holding SE stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 1 | 1 | 2 |
| Hold | 2 | 2 | 2 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Maintains €44.00 | Hold | Maintains | €44.00 | +9.18% | Aug 18, 2026 |
| Berenberg Bank | Berenberg Bank | Buy Maintains €44.00 → €60.00 | Buy | Maintains | €44.00 → €60.00 | +48.88% | May 14, 2026 |
Financial Forecast
Revenue This Year
1.21B
from 1.18B
Increased by 2.56%
Revenue Next Year
1.25B
from 1.21B
Increased by 3.80%
EPS This Year
2.48
from 2.56
Decreased by -2.81%
EPS Next Year
2.93
from 2.48
Increased by 17.87%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.